ZYBERNO
Stock Report
Updated Aug 26, 2026

NUTRIBAND INC. (NTRBW)

Healthcare • NASDAQ

$0.52

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
24.0/100
POOR BUSINESS
NUTRIBAND INC. (NTRBW) scores 24/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-112.6%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.12x)
Operating Margin (Operational Efficiency):CRITICAL (-452.6%)
Return on Capital (Capital Efficiency):CRITICAL (-229.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

NUTRIBAND INC. (NTRBW) stock report — Zyberno Score 24/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, NTRBW generated -$5.14M in Owner Earnings. Capital was deployed as follows: $5.32K invested in capital expenditures. Reinvestment rate: 3.1%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.52
Market Cap:$6.35M

Valuation Multiples (3)

P/B Ratio:1.06x
P/S Ratio:3.52x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$3.02M

Price Action & Momentum (3)

Momentum Percentile:13 / 100
% of 52-Week High:17.5%
B. Profitability Assessment

Return Metrics (5)

ROA:-97.9%
Reinvestment Rate:3.1%
Fundamental Growth Rate (g):-7.1%

Margin Analysis (3)

Operating Margin Ttm:-452.6%
Net Margin Ttm:-448.4%
Ebitda Margin:-439.9%

TTM Performance (3)

Gross Margin Ttm:31.4%
Operating Margin Ttm:-452.6%
Net Margin Ttm:-448.4%

Yield Metrics (2)

Earnings Yield:-$489.95
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:64.3%
Latest Earnings Filed:2026-06-11

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):9.4%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:5.26x
Quick Ratio:5.11x
Cash Ratio:4.81x

Leverage Analysis (3)

Debt To Equity Ttm:0.12x
Debt-to-Equity Ratio:0.12x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-383.97x
Times Interest Earned:-383.97

Capital Structure (4)

Working Capital:3,544,125.00
Cash And Cash Equivalents:4,006,184.00
Long Term Debt:$40.35K
Net Debt:-$3.33M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.80M
Linear Growth: 9.4%
📊 Click to view full NTRBW Revenue analysis & methodology →
Cost Of Revenue Ttm:$1.29M

Profitability Breakdown (2)

Gross profit TTM: $566.31K
Linear Growth: -16.8%
📊 Click to view full NTRBW Gross Profit analysis & methodology →
-$8.16M

Bottom Line Performance (3)

-$8.08M
Income Before Tax:-$8.08M
Ebitda Ttm:-7,929,702.00

Operating Expenses (5)

Operating Expenses:8,906,541.00
R And D Expense:1,454,964.00
Sga Expense:7,214,979.00
Income Tax Expense:$0.00
Interest Expense:21,663.00

Expense Ratios (3)

R And D To Revenue Percentage:335.7%
Sga To Revenue Percentage:1,664.7%
Ebitda Margin:-439.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$6.89M
Current Assets:$4.38M
Ppe Net:548,244.00
Goodwill:1,719,535.00
Intangible Assets:$185.26K

Liability Structure (4)

Total Liabilities:902,312.00
Current Liabilities:832,137.00
Long Term Debt:$40.35K
Short Term Debt:$639.19K

Equity & Capital (3)

Equity:$5.99M
Retained Earnings:-$47.93M
Common Stock:291,666,666.00

Working Capital Items (3)

Accounts Receivable:2,632.00
Inventory:121,494.00
Accounts Payable:639,192.00

Special Items (2)

Contract Liabilities:30,406.00
Stock Based Compensation:552,458.00
C. Cash Flow Analysis

Operating Activities (2)

-$4.36M-$4.37M

Investment Activities (2)

Investing Cash Flow:$0.00
Capital Expenditures Ttm:5,324.00

Financing Activities (3)

Financing Cash Flow:-$5.57K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:8,400,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:229,113.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-2.56
-$2.56
Earnings Per Share Ttm:-$0.66

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.15
Operating Cash Flow Per Share:-$0.42

Book Value & Capital (2)

Book Value Per Share:$0.49
Cash Per Share:0.33

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.22x
Working Capital Turnover Ttm:0.51x

Receivables Management (2)

Receivables Turnover Ttm:684.89x
Days Sales Outstanding Ttm:0.53

Inventory Management (2)

Inventory Turnover Ttm:10.63x
Days Inventory Outstanding Ttm:34.34

Payables & Cash Cycle (2)

Days Payable Outstanding:180.65
Cash Conversion Cycle:-145.78
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$5.14M

Damodaran Growth Analysis (2)

Reinvestment Rate:3.1%
Fundamental Growth Rate (g):-7.1%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):9.4%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-16.8%
Book Value Growth Rate (Linear):-5.8%
C. Company Profile & Context

Corporate Information (6)

Symbol:NTRBW
Company Name:NUTRIBAND INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:12.16M
Shares Outstanding Basic:12.16M
Shares Outstanding Diluted:12.16M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-26 04:43:33 UTC
Data Timestamp:2026-08-26T04:43:33.925037
Scroll to Top